Jump to main content
Jump to site search

Issue 18, 2017
Previous Article Next Article

Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation

Author affiliations

Abstract

Gold nanoparticles (17 nm) have been functionalized with the antiangiogenic monoclonal antibody drug Cetuximab at a well-defined orientation and coverage density of antibodies. Functionalization has been carried out through site-directed chemistry via the selective oxidation of the carbohydrate moiety of antibodies linked to a thiolated hydrazide. A431 tumor cells have been exposed to these conjugates for in vitro evaluation of their effects. In addition to epithelial growth factor receptor blocking, trafficking and signaling alterations were also observed. Thus, the blocking effects of Cetuximab were increased and sustained for a longer time when associated with the nanoparticles. Enhancing antibody therapy effects by decreasing the needed dose and prolonging its effect by avoiding receptor recycling may serve to obtain increased therapeutic benefits for immunotherapy.

Graphical abstract: Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Feb 2017, accepted on 02 Apr 2017 and first published on 05 Apr 2017


Article type: Paper
DOI: 10.1039/C7NR00947J
Citation: Nanoscale, 2017,9, 6111-6121
  •   Request permissions

    Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation

    L. García-Fernández, J. Garcia-Pardo, O. Tort, I. Prior, M. Brust, E. Casals, J. Lorenzo and V. F. Puntes, Nanoscale, 2017, 9, 6111
    DOI: 10.1039/C7NR00947J

Search articles by author

Spotlight

Advertisements